COVID-19 is associated with high blood glucose levels: Diabetic neuropathy during the SARS-CoV-2 pandemic

Author:

Bereda Gudisa1ORCID

Affiliation:

1. Alert Comprehensive Specialized Hospital

Abstract

Abstract Background: The nerves in the legs and feet are most frequently damaged by diabetic neuropathy. The COVID-19 infection is associated with a high risk of neuropathy symptoms. Case Presentation: On July 12, 2022, a 58-year-old black female retiree with significant symptoms of numbness and muscle weakness in the hands and legs was brought into the emergency room. 17 years prior, she received a type 2 diabetes mellitus diagnosis. Metformin 1.5 g twice a day and glibenclamide 10 mg twice a day were part of her therapy regimen. When she was admitted to the emergency room, she described a one-day history of shortness of breath, frequent urination, excessive thirst, hyperglycemia, excessive appetite, fever, headache, and dehydration. A chest X-ray showed bilateral diffuse, patchy airspace opacities that could be caused by multifocal pneumonia or viral pneumonia. She started receiving 1000 mL of fluid resuscitation (0.9% normal saline) as soon as she was moved to the critical care unit, along with a drip-in insulin infusion. Conclusion: Diabetes, infections like COVID-19, poor vitamin levels, and other factors can all contribute to diabetic neuropathies. According to the Centers for Disease Control and Prevention, patients with type 2 diabetes mellitus are much more likely to experience severe morbidity and death from coronavirus disease-19. Symptoms of diabetic neuropathy continued for months after a COVID-19 infection test resulted in a positive result.

Publisher

Research Square Platform LLC

Reference23 articles.

1. Risk Factors, Classifications and Pathogenesis of Diabetic Neuropathy;Bereda G;J Diabetes Metab Disord,2022

2. Newly diagnosed diabetes mellitus, DKA, and COVID-19: Causality or coincidence? A report of three cases;Suwanwongse K;Journal of medical virology,2021

3. Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019;Hayden MR;Journal of International Medical Research,2020

4. Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. The lancet Diabetes & endocrinology. 2020 Sep 1;8(9):782 – 92.

5. Comorbidity and its impact on patients with COVID-19. SN comprehensive clinical medicine;Sanyaolu A,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3